{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:50:41Z","timestamp":1793026241472,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":169,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1RM1DA059375"],"award-info":[{"award-number":["1RM1DA059375"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.josat.2025.209837","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:16:53Z","timestamp":1763763413000},"page":"209837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Retention among Medicaid beneficiaries in opioid treatment programs in California"],"prefix":"10.1016","volume":"181","author":[{"given":"William N.","family":"Dowd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Barch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami L.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrett W.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"DeLisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh T.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Zarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.josat.2025.209837_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.4001","article-title":"Coverage and prior authorization policies for medications for opioid use disorder in Medicaid managed care","volume":"3","author":"Abraham","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.josat.2025.209837_bb0010","series-title":"The reliability of provider profiling: A tutorial","author":"Adams","year":"2009"},{"key":"10.1016\/j.josat.2025.209837_bb0015","author":"American Society of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209837_bb0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/07853890.2023.2171107","article-title":"Prior authorization restrictions on medications for opioid use disorder: Trends in state laws from 2005 to 2019","volume":"55","author":"Andraka-Christou","year":"2023","journal-title":"Annals of Medicine"},{"issue":"5","key":"10.1016\/j.josat.2025.209837_bb0025","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1360-0443.2009.02538.x","article-title":"Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users","volume":"104","author":"Banta-Green","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209837_bb0030","article-title":"Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application","volume":"209441","author":"Bowser","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"2","key":"10.1016\/j.josat.2025.209837_bb0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2021.7374","article-title":"Use of medications for treatment of opioid use disorder among US Medicaid enrollees in 11 states, 2014\u20132018","volume":"326","author":"Brown","year":"2021","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.josat.2025.209837_bb0040","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/add.15959","article-title":"Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: A retrospective cohort study","volume":"117","author":"Burns","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209837_bb0045","unstructured":"California Department of Health Care Services. (2025). Data compliance standards: California outcomes measurement system treatment (CalOMS Tx). https:\/\/www.dhcs.ca.gov\/provgovpart\/Documents\/Data-Compliance-Standards-V3-Jan-2025.pdf."},{"issue":"4","key":"10.1016\/j.josat.2025.209837_bb0050","doi-asserted-by":"crossref","first-page":"e253099","DOI":"10.1001\/jamanetworkopen.2025.3099","article-title":"Medicare beneficiary receipt of methadone by drive time to opioid treatment programs","volume":"8","author":"Cantor","year":"2025","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209837_bb0055","unstructured":"Centers for Medicare and Medicaid Services. (2023). Risk adjustment and risk stratification in quality measurement,. https:\/\/mmshub.cms.gov\/sites\/default\/files\/Risk-Adjustment-in-Quality-Measurement.pdf."},{"key":"10.1016\/j.josat.2025.209837_bb0060","unstructured":"Centers for Medicare and Medicaid Services. (2024). Measures management system: Measure evaluation criteria \u2014 Reliability. https:\/\/mmshub.cms.gov\/measure-lifecycle\/measure-testing\/evaluation-criteria\/scientific-acceptability\/reliability."},{"key":"10.1016\/j.josat.2025.209837_bb0065","unstructured":"Centers for Medicare and Medicaid Services. (n.d.). CMS care compare. https:\/\/www.medicare.gov\/care-compare\/?providerType=NursingHome."},{"key":"10.1016\/j.josat.2025.209837_bb0070","unstructured":"City of Los Angeles Public Health. (2024). CalOMS\/LACPRS data collection quick user guide. http:\/\/publichealth.lacounty.gov\/sapc\/docs\/providers\/caloms\/CalOMS-Quick-User-Guide.pdf."},{"issue":"1","key":"10.1016\/j.josat.2025.209837_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2012.03.002","article-title":"Predictors of methadone program non-retention for opioid analgesic dependent patients","volume":"44","author":"Cox","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2025.209837_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e31829727b2","article-title":"Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","volume":"7","author":"Cunningham","year":"2013","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209837_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109445","article-title":"Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder","volume":"235","author":"Golan","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2025.209837_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13722-024-00527-w","article-title":"Organization of primary care and early MOUD discontinuation","volume":"19","author":"Harris","year":"2024","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2025.209837_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-12-238","article-title":"Methadone treatments in a Swiss Region, 2001\u20132008: A registry-based analysis","volume":"12","author":"Huissoud","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.josat.2025.209837_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10742-020-00226-4","article-title":"Defining and estimating the reliability of physician quality measures in hierarchical logistic regression models","volume":"21","author":"Hwang","year":"2021","journal-title":"Health Services and Outcomes Research Methodology"},{"key":"10.1016\/j.josat.2025.209837_bb0105","article-title":"Audit and feedback: Effects on professional practice and healthcare outcomes","volume":"6","author":"Ivers","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2025.209837_bb0110","article-title":"Audit and feedback: Effects on professional practice","volume":"3","author":"Ivers","year":"2025","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2025.209837_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2025.209837_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/02791072.2015.1014948","article-title":"Changes in quality of life following buprenorphine treatment: Relationship with treatment retention and illicit opioid use","volume":"47","author":"Mitchell","year":"2015","journal-title":"Journal of Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.josat.2025.209837_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ajad.12896","article-title":"Long-term retention in an outpatient behavioral health clinic with buprenorphine","volume":"28","author":"Montalvo","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2025.209837_bb0130","unstructured":"National Center for Health Statistics. (2025). Drug overdose mortality by state. https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/drug_poisoning_mortality\/drug_poisoning.htm."},{"key":"10.1016\/j.josat.2025.209837_bb0135","series-title":"Principles of Drug Addiction Treatment: A Research-based Guide","author":"National Institute on Drug Abuse","year":"2018"},{"key":"10.1016\/j.josat.2025.209837_bb0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tranpol.2024.08.001","article-title":"Affordable transportation access to treatment for opioid use disorder","volume":"156","author":"Ngo","year":"2024","journal-title":"Transport Policy"},{"issue":"6","key":"10.1016\/j.josat.2025.209837_bb0145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/aje\/kwp186","article-title":"Proportional hazards frailty models for recurrent methadone maintenance treatment","volume":"170","author":"Nosyk","year":"2009","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1016\/j.josat.2025.209837_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232086","article-title":"Retention of patients in opioid substitution treatment: A systematic review","volume":"15","author":"O\u2019Connor","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2025.209837_bb0155","series-title":"APHA\u2019s 2018 annual meeting & expo (Nov. 10\u2013Nov. 14)","article-title":"Early recovery specialists increase 90-day retention rates at Medication-Assisted Treatment programs for opioid addiction: Findings from a pilot study in California","author":"Ong","year":"2018"},{"issue":"1","key":"10.1016\/j.josat.2025.209837_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13722-022-00316-3","article-title":"Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities","volume":"17","author":"Pasman","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.josat.2025.209837_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10550880802324382","article-title":"One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel","volume":"27","author":"Peles","year":"2008","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.josat.2025.209837_bb0170","unstructured":"Pew Charitable Trusts. (2024). Most states already collect data that can help improve opioid use disorder treatment. https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/articles\/2024\/05\/28\/most-states-already-collect-data-that-can-help-improve-opioid-use-disorder-treatment."},{"key":"10.1016\/j.josat.2025.209837_bb0175","author":"R Core Team"},{"key":"10.1016\/j.josat.2025.209837_bb0180","author":"Research Data Assistance Center"},{"issue":"9","key":"10.1016\/j.josat.2025.209837_bb0185","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2025.209837_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ADT.0000000000000099","article-title":"Factor predictive of 1-year retention on methadone maintenance therapy program: A survival analysis study","volume":"16","author":"Shakira","year":"2017","journal-title":"Addictive Disorders & Their Treatment"},{"issue":"12","key":"10.1016\/j.josat.2025.209837_bb0195","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/add.14398","article-title":"High-intensity cannabis use is associated with retention in opioid agonist treatment: A longitudinal analysis","volume":"113","author":"Soc\u00edas","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209837_bb0200","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"bmj"},{"key":"10.1016\/j.josat.2025.209837_bb0205","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Brief report: Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2025.209837_bb0210","unstructured":"Substance Abuse and Mental Health Services Administration. (n.d.). Opioid treatment program directory. https:\/\/dpt2.samhsa.gov\/treatment\/."},{"issue":"4","key":"10.1016\/j.josat.2025.209837_bb0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1077558720931652","article-title":"Two decades of nursing home compare: What have we learned?","volume":"78","author":"Tamara Konetzka","year":"2021","journal-title":"Medical Care Research and Review"},{"key":"10.1016\/j.josat.2025.209837_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209055","article-title":"Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder","volume":"150","author":"Thakrar","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209837_bb0225","author":"Van Dyke"},{"issue":"5","key":"10.1016\/j.josat.2025.209837_bb0230","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ADM.0b013e31829da05b","article-title":"A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi\u2019an","volume":"7","author":"Wei","year":"2013","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209837_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2025.209837_bb0240","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1377\/hlthaff.2008.0770","article-title":"Public reporting on hospital process improvements is linked to better patient outcomes","volume":"29","author":"Werner","year":"2010","journal-title":"Health Affairs"},{"issue":"1","key":"10.1016\/j.josat.2025.209837_bb0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0000000000000263","article-title":"Medication adherence in patients undergoing methadone maintenance treatment in Xi\u2019an, China","volume":"11","author":"Zhou","year":"2017","journal-title":"Journal of Addiction Medicine"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:01:35Z","timestamp":1784581295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S2949875925002164"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209837","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retention among Medicaid beneficiaries in opioid treatment programs in California","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209837"}}